We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Crizotinib-Associated Renal Cysts in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients: A Single-Center Experience.
- Authors
Eiamprapaporn, Panuch; Mungwatthana, Naphapatt; Twinprai, Prin; Sookprasert, Aumkhae; Chindaprasirt, Jarin; Ahooja, Anucha; Watthanaudomrot, Sirinthip; Sirithanaphol, Wichien
- Abstract
Crizotinib is an anaplastic lymphoma kinase (ALK) inhibitor that was approved for ALK-harboring lung cancer. There have been reports about the development and progression of renal cysts from crizotinib. We report a series of 3 cases of crizotinib-associated renal cysts in patients admitted to our institution, with different kinds of presentation. A monitor for complex renal cysts is warranted in patients receiving crizotinib.
- Subjects
ANAPLASTIC lymphoma kinase; CRIZOTINIB; CYSTIC kidney disease; LUNG cancer; CANCER patients; NON-small-cell lung carcinoma; ANAPLASTIC thyroid cancer
- Publication
Urologia Internationalis, 2020, Vol 104, Issue 3-4, p269
- ISSN
0042-1138
- Publication type
Article
- DOI
10.1159/000502664